Skip to main content
Caplight Logo









HJ Partners

HJ Partners

Overview

HJ Partners is a healthcare-focused private equity investment firm that invests in medtech, life sciences, and biotech sectors.

Year Founded

2023

Portfolio Companies

1

Investments

HJ Partners investments
CompanyDateStageLead
Shanghai Easy-Flow Medical Tech Co., Ltd.Apr 2025Series A ExtensionCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is HJ Partners based?

HJ Partners is headquartered in Beijing, China.

When was HJ Partners founded?

HJ Partners was founded in 2023.

How many portfolio companies does HJ Partners have?

HJ Partners has 1 portfolio company in Caplight's dataset.

What are some companies in HJ Partners's portfolio?

Recent investments visible on Caplight include Shanghai Easy-Flow Medical Tech Co., Ltd..

What was HJ Partners's most recent investment?

HJ Partners's most recent investment on Caplight was in Shanghai Easy-Flow Medical Tech Co., Ltd. in 2025.

What sectors does HJ Partners focus on?

HJ Partners focuses on Healthcare & Life Sciences, Frontier & Industrial Tech.

What company stages does HJ Partners focus on?

HJ Partners typically invests at the Early stage.

What is HJ Partners's AUM?

HJ Partners's assets under management are estimated between $1.5B and $1.5B.

Firmographic Details

HeadquartersBeijing
Year Founded2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?